Health news
The Food and Drug Administration (FDA) has cleared Smith+Nephew’s PICO 7 and PICO 14 Single Use Negative Pressure Wound Therapy (sNPWT) Systems for use on closed surgical incisions to aid in reducing the incidence of…
The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Merck regarding the New Drug Application for gefapixant for the treatment of adults with refractory or unexplained chronic cough. Gefapixant is…
Purified Cortrophin Gel (repository corticotropin injection USP) is now available for the treatment of certain chronic autoimmune disorders, including but not limited to acute exacerbations of multiple sclerosis, rheumatoid arthritis, and excess urinary protein due…
The Food and Drug Administration (FDA) has approved Skyrizi® (risankizumab-rzaa) for the treatment of adults with active psoriatic arthritis (PsA). Skyrizi is also indicated for the treatment of moderate to severe plaque psoriasis in adults…
COVID-19 vaccination was not associated with impaired fertility in either males or females, according to a study funded by the National Institutes of Health (NIH). To examine the association between COVID-19 vaccination and SARS-CoV-2 infection…
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for E4/DRSP (estetrol and drospirenone; Mayne Pharma) for the prevention of pregnancy. The novel combined oral contraceptive pill includes estetrol…
Gilead Sciences has announced the removal of counterfeit and tampered Gilead-labeled HIV medications, including bottles labeled as Biktarvy® (bictegravir, emtricitabine, tenofovir alafenamide) and Descovy® (emtricitabine and tenofovir alafenamide), from the US supply chain. Biktarvy is…
Gilead Sciences has voluntarily withdrawn the US indications for Zydelig® (idelalisib) for the treatment of relapsed follicular B-cell non-Hodgkin lymphoma (FL) and relapsed small lymphocytic leukemia (SLL). In 2014, Zydelig received accelerated approval for these…
The Food and Drug Administration (FDA) has approved Ryaltris (olopatadine hydrochloride, mometasone furoate) nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis in adults and pediatric patients 12 years of age and…
The safety and efficacy of a shorter 5-day course of antibiotics were found to be comparable to a standard 10-day course in children with uncomplicated community-acquired pneumonia (CAP), according to the findings of a clinical…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021